Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Halozyme Therapeutics Inc. | 1.500% | 4.955% | 1.161% | 36.393% | 13.264% | -1.969% | - |
| aTyr Pharma Inc | - | 0.000% | -13.609% | -21.505% | 13.178% | -51.656% | -80.022% |
| Regeneron Pharmaceuticals Inc. | 1.120% | 8.074% | 3.749% | 30.470% | 13.129% | 121.127% | 212.180% |
| Puma Biotechnology Inc. | -0.280% | -2.905% | -15.479% | 53.997% | 12.983% | -45.111% | - |
| Syndax Pharmaceuticals Inc | 1.940% | 9.375% | -4.545% | 9.375% | 12.299% | 57.895% | - |
| Neurocrine Bioscience | 0.420% | 3.260% | 3.702% | 50.509% | 11.526% | 77.684% | 86.188% |
| Chimerix Inc. | -0.790% | 11.323% | -2.199% | -10.920% | 11.270% | -86.039% | -61.245% |
| Akebia Therapeutics Inc. | -3.820% | 10.289% | -5.398% | 34.126% | 10.666% | -49.336% | - |
| Biolife Solutions Inc | -1.200% | 1.235% | 2.500% | 1.863% | 10.067% | -35.433% | 7.036% |
| Atara Biotherapeutics Inc. | -4.550% | -17.129% | -23.165% | -76.981% | 9.867% | -95.000% | - |
| Xencor Inc. | -0.890% | 20.856% | 14.141% | -8.871% | 9.709% | -35.244% | - |
| Capricor Therapeutics Inc | -1.120% | -0.811% | -22.010% | 42.358% | 9.274% | 70.979% | - |
| AbbVie Inc. | 0.030% | -0.866% | -3.722% | 12.480% | 7.823% | 58.810% | 117.948% |
| Omeros Corp. | -1.640% | 14.676% | 8.108% | -27.210% | 7.211% | -76.796% | -78.791% |
| Celldex Therapeutics | -2.530% | 10.227% | 6.011% | 28.477% | 7.182% | 75.884% | 630.697% |
| Cara Therapeutics Inc. | -1.350% | 4.354% | -9.002% | -81.294% | 7.138% | -92.807% | -95.629% |
| Amgen Inc. | 0.520% | 8.744% | 12.061% | 29.981% | 7.137% | 33.684% | 80.129% |
| Supernus Pharmaceuticals | -0.710% | -0.709% | -7.285% | -15.663% | 6.870% | 15.702% | -18.057% |
| Immucell Corp | 2.170% | -0.844% | 0.858% | 6.335% | 6.335% | -42.331% | -13.204% |
| Ligand Pharmaceuticals | -1.450% | 2.256% | -5.556% | -6.207% | 4.615% | -35.207% | -38.462% |
| Voyager Therapeutics Inc | -2.750% | 14.463% | -3.428% | 19.568% | 4.528% | 134.878% | - |